Diagnosis of invasive pulmonary nodules and prediction of tumor invasiveness in lung cancer patients remains challenging. Here, mass cytometry analysis of peripheral blood samples from 1032 patients and a machine learning approach, the SMART platform, allow differential diagnosis and surgical management of small pulmonary nodules.
